• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Morgan Stanley defends Microsoft, sees a ‘strong demand signal’ By Investing.com

November 29, 2022 admin 0

© Reuters. Morgan Stanley defends Microsoft (MSFT), sees a ‘strong demand signal’ By Senad Karaahmetovic Morgan Stanley analysts reiterated an Overweight rating on Microsoft (NASDAQ:) stock and a $307 per share price target. Despite recent […]

Stock News

Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.05% By Investing.com

November 29, 2022 admin 0

© Reuters. Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.05% Investing.com – Saudi Arabia stocks were higher after the close on Tuesday, as gains in the , and sectors led […]

Stock News

New York Community Bancorp: Undervalued, Yielding 7%, And Approved Acquisition (NYSE:NYCB)

November 29, 2022 admin 0

Enes Evren It’s been several weeks since New York Community Bancorp (NYSE:NYCB) reported its Q3 earnings. Despite the slight miss, Q3 was relatively good as revenue, net income, loans, and deposits all increased in the […]

Posts navigation

« 1 … 2,883 2,884 2,885 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Papa John’s Leaves Something To Be Desired (NASDAQ:PZZA)
    November 3, 2022 0
  • Mizuho Securities to buy 20% of Rakuten Securities for $550 million By Reuters
    October 7, 2022 0
  • Akamai Technologies, Inc. (AKAM) CEO Thomson Leighton on Q2 2022 Results – Earnings Call Transcript
    August 10, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.